Nonoxynol-9 Dangers: Health Experts Warn Against Rectal Use

AIDS TREATMENT NEWS Issue #384, October 18, 2002
John S. James


On September 27 over 80 health experts and organizations released a letter warning against all rectal use of nonoxynol-9 (N-9) -- a spermicide mistakenly used to kill HIV, when actually it makes transmission worse. The letter came after a quiet campaign that persuaded most but not all manufacturers to remove the substance from their products. Experts agree that rectal use is dangerous and never appropriate -- and that N-9 should not be included in any condoms or lubricant.

On October 10 the Bay Area Reporter, a San Francisco gay newspaper, reported that all lubricant manufacturers had now promised to stop making lubricant with N-9. This followed an earlier series of articles in the B.A.R. that prompted some local retailers to remove N-9 products from their shelves.

>From the September 27 consensus letter:

"Call to Discontinue Nonoxynol-9 for Rectal Use

"We, the undersigned, in light of recent statements by the World Health Organization and the Centers for Disease Control, urge all people to cease the rectal use of products containing Nonoxynol-9 (N-9). We are concerned that many people mistakenly believe that N-9 provides extra protection against HIV and STDs when used rectally when in fact there is reason to think that rectal use of N-9 may increase risk of infection.

"The Centers for Disease Control states: 'N-9 can damage the cells lining the rectum, thus providing a portal of entry for HIV and other sexually transmissible agents. Therefore, N-9 should not be used as a microbicide or lubricant during anal sex.'

"The World Health Organization states: 'N-9 should not be used rectally.' (Further) 'There is no published scientific evidence that N-9-lubricated condoms provide any additional protection against pregnancy or STIs compared with condoms lubricated with other products.

"'Since adverse effects due to the addition of N-9 to condoms cannot be excluded, such condoms should no longer be promoted.'"

For More Information

021018
ATN38409


Copyright © 2002 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .